SCHEMBL4468068

SCHEMBL4468068

COC(=O)NC(=O)C1C=CC=C2Oc3ncccc3C(=CCCN3CCC(O)(c4ccc(Cl)cc4)CC3)C=C21

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.36
OPRM1 P35372 2/20 0.36
OPRL1 P41146 1/20 0.36
CCR1 P32246 3/20 0.35
TMEM97 Q5BJF2 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
DRD4 P21917 1/20 0.33
HRH2 P25021 1/20 0.33
SLC6A4 P31645 1/20 0.33
ADRA1A P35348 1/20 0.33
HRH1 P35367 1/20 0.33
KCNH2 Q12809 1/20 0.33
SCN5A Q14524 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
ALDH1A1 P00352 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL654063 0.92 OPRM1 (0.38) DRD2OPRM1OPRL1CCR1ADRA2A
SCHEMBL654382 0.90 DRD2 (0.35) DRD2OPRM1OPRL1CCR1TMEM97
SCHEMBL655037 0.90 DRD2 (0.38) DRD2OPRM1OPRL1CCR1SIGMAR1
SCHEMBL654871 0.90 DRD2 (0.36) DRD2CCR1ADRA1A
SCHEMBL655209 0.89 DRD2 (0.34) DRD2OPRM1OPRL1CCR1TMEM97
SCHEMBL655822 0.89 DRD2 (0.35) DRD2OPRM1OPRL1CCR1ADRA1A
SCHEMBL653963 0.88 DRD2 (0.37) DRD2OPRM1OPRL1CCR1DRD4
SCHEMBL655073 0.88 CCR1 (0.37) DRD2OPRM1OPRL1CCR1TMEM97
SCHEMBL658798 0.88 CCR1 (0.35) DRD2OPRM1OPRL1CCR1SIGMAR1
SCHEMBL653148 0.88 DRD2 (0.38) DRD2OPRM1OPRL1CCR1TMEM97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541365-B2 Chemokine receptor antagonists and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. (US) 2009-06-02 US disclosed